Breakthrough T1D’s NYC Promise Gala 2026 Honors National Diabetes Awareness Month
NEW YORK, Nov. 18, 2026
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.

![]()
Breakthrough T1D’s NYC Promise Gala 2026 Honors National Diabetes Awareness Month
PR Newswire
NEW YORK, Nov. 18, 2026
GRAMMY®-nominated musician Este Haim to Emcee Breakthrough T1D’s 53rd Annual New York City Promise Gala; Peter Hill to Be Honored as Humanitarian of the Year
Cell Therapy Clinical Trial Participant Who No Longer Requires Insulin Highlights the Promise of Breakthrough T1D Funded Research
NEW YORK, Nov. 18, 2026 /PRNewswire/ — Tonight, Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, will host its 53rd Annual New York City Promise Gala at the historic Plaza Hotel. For more than five decades, the Promise Gala has been one of New York’s signature nights for philanthropy and the T1D community, raising more than $85 million to date. The gala is co-chaired by Allison Aston and Bonnie Bergstein, with Jim Nadler serving as corporate chair, Christopher Evans as fundraising chair and auction co-chairs Deborah Soss and Gail Victor. GRAMMY®-nominated musician Este Haim, who lives with T1D, will serve as emcee. Haim, a musician, composer, actor and writer, has used her voice and platform to champion the T1D community through her work with Breakthrough T1D.
“I was 14 when I was diagnosed, and I’ve managed type 1 diabetes every day since — on stage, on the road and everywhere in between,” said GRAMMY®-nominated musician Este Haim. “Hosting the Breakthrough T1D Promise Gala is a chance to celebrate the T1D community and raise funds that will help push research toward cures for type 1 diabetes.”
Funds raised at the Promise Gala help advance research by supporting grants that move potential T1D cures into clinical trials and bring new treatment possibilities closer to reality. The impact of this investment is reflected in the lives of people like Katie Beth Hand, a mother of four whose participation in a Breakthrough T1D funded cell therapy clinical trial has allowed her to live without the need for insulin. A powerful example of how philanthropic support can help turn scientific progress into real possibilities for people living with T1D.
“I am incredibly grateful for the generosity of everyone who supports Breakthrough T1D. Research funding made possible by donors and events like the Promise Gala mean encouraging scientific discoveries can move forward into clinical trials and those trials have the potential to transform lives. I am living proof of what that investment can make possible,” said Katie Beth Hand. “After years of living with type 1 diabetes and managing the constant burden of insulin doses and health decisions, achieving insulin independence through a clinical trial has given me freedom I never thought possible.”
Peter Hill will be recognized as the 2026 Promise Gala Humanitarian of the Year. Hill is senior managing director of Ramirez & Co. and is a past president of the Breakthrough T1D New York City Chapter Board. Hill has helped raise more than $2 million for Breakthrough T1D, including more than $500,000 through Breakthrough T1D’s Run program. For Hill, the fight against T1D is personal. Several of Hill’s family members live with T1D, including his daughter Sheila, who was diagnosed in 2019. Sheila and her husband, San Diego Padres pitcher and former New York Yankee, Michael King are expected to be on hand for tonight’s festivities.
“Type 1 diabetes has touched my family personally, and that experience has strengthened my commitment to supporting the T1D community. I’m honored to be recognized by Breakthrough T1D and proud to help advance research that can improve lives and move us closer to cures.”
The gala opens at 6:00 p.m. with a cocktail reception and silent auction, followed by dinner, a live auction and Breakthrough T1D’s signature Fund A Cure program, in which 100% of contributions go directly to Breakthrough T1D’s mission.
“The Promise Gala brings the type 1 diabetes community together around a shared purpose: raising awareness, improving lives and advancing research toward T1D cures,” said Katie Schafer, New York territory executive for Breakthrough T1D. “It’s always special to come together during November, National Diabetes Awareness Month to shine a light on the realities of living with T1D, celebrate the dedication of our community, recognize the generosity of those who champion our mission and the urgent need for continued progress.”
Event Photos Available Upon Request
About Breakthrough T1D, Formerly JDRF
Breakthrough T1D is the leading global type 1 diabetes research and advocacy organization. It works to improve everyday life for people with T1D while advancing toward cures through research investment, advocacy, education and community support.
About Type 1 Diabetes (T1D)
T1D is an autoimmune condition in which the pancreas makes very little or no insulin. People with T1D depend on insulin therapy and face the risk of short- and long-term complications, including blood sugar highs and lows and damage to the kidneys, eyes, nerves and heart. T1D affects nearly 9 million people globally. It can be diagnosed at any age, and its onset is unrelated to diet or lifestyle. There is currently no cure.
Contact:
Chelsea-Lyn Rudder
646-946-0513
media@breakthroughT1D.org
View original content to download multimedia:https://www.prnewswire.com/news-releases/breakthrough-t1ds-nyc-promise-gala-2026-honors-national-diabetes-awareness-month-302944260.html
SOURCE Breakthrough T1D, Formerly JDRF

